Gemma Azaceta

Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes

Sheri Skerget, Daniel Peñaherrera, Ajai Chari et al. · Nature Genetics · 2024 · 75 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Iminophosphorane–organogold(III) complexes induce cell death through mitochondrial ROS production

Laura Vela, Marı́a Contel, Luis Palomera et al. · Journal of Inorganic Biochemistry · 2011 · 62 citations · Full text

Life Sciences, Biochemistry, Cell Biology +15

Human NK cells activated by EBV⁺lymphoblastoid cells overcome anti-apoptotic mechanisms of drug resistance in haematological cancer cells

Diego Sánchez‐Martínez, Gemma Azaceta, Aura Muntasell et al. · OncoImmunology · 2015 · 42 citations · Full text

Life Sciences, Immunology, Oncology +16

Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patients

Chantal Reina-Ortiz, Michael G. Constantinides, Alexis Fayd’herbe de Maudave et al. · OncoImmunology · 2020 · 39 citations · Full text

Medicine, Immunology, Oncology +17

Expanded and activated allogeneic NK cells are cytotoxic against B-chronic lymphocytic leukemia (B-CLL) cells with sporadic cases of resistance

Tania Calvo, Chantal Reina-Ortiz, David Giraldos et al. · Scientific Reports · 2020 · 38 citations · Full text

Life Sciences, Immunology, Oncology +17